John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research, Professor of Psychiatry, Neuroscience and Psychology, and Chair of the Yale Department of Psychiatry, was among four expert panelists who spoke on videos recorded at The International College of Neuropsychopharmacology (CINP) 2019 International Meeting in Athens on October 3-5, 2019.
Krystal, Past President of CINP, was accompanied on the panel by leaders in the field of neuropsychopharmacology, including current CINP President Dr. Siegfried Kasper from the Medical University of Vienna, Austria; Dr. Gabriella Gobbi from McGill University in Canada; and Dr. Carol Tamminga of UT Southwestern Medical Center.
The panelists discussed the following topics:
- Part 1: Treatment-Resistant Depression
- Part 2: Use of Cannabinoids in Psychiatric Patients
- Part 3: New Treatments for Treatment-Resistant Depression
- Part 4: New Medication for Schizophrenia
CINP is an international organization that promotes the scientific study, teaching, and application of neuropsychopharmacology. Its 2020 World Congress will be held in Taipei, Taiwan in June 2020.